Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Hattersley

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The Medical Journal of Australia|October 13, 2017
The prevalence of monogenic diabetes in Australia: the Fremantle Diabetes Study Phase IITimothy Me Davis, Ashley E Makepeace, Sian Ellard, et al.
Drug Discovery Today|November 8, 2016
Defining drug response for stratified medicineMike Lonergan, Stephen J Senn, Christine McNamee, et al.
Clinical Epigenetics|July 20, 2018
Genome-wide methylomic analysis in individuals with HNF1B intragenic mutation and 17q12 microdeletionRhian L Clissold, Beth Ashfield, Joe Burrage, et al.
Diabetes Care|September 19, 2014
Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetesNele Myngheer, Karel Allegaert, Andrew Hattersley, et al.
BMJ Global Health|May 21, 2021
Associations between low HDL, sex and cardiovascular risk markers are substantially different in sub-Saharan Africa and the UK: analysis of four population studiesRosamund Greiner, Moffat Nyrienda, Lauren Rodgers, et al.
Diabetes Research and Clinical Practice|May 17, 2017
A successful transition to sulfonylurea treatment in male infant with neonatal diabetes caused by the novel abcc8 gene mutation and three years follow-upDragan Katanic, Ivana Vorgučin, Andrew Hattersley, et al.
BMC Medical Genetics|May 21, 2017
Pancreas and gallbladder agenesis in a newborn with semilobar holoprosencephaly, a case reportRobert Hilbrands, Kathelijn Keymolen, Alex Michotte, et al.
BMJ Open|March 21, 2020
Strategies to identify individuals with monogenic diabetes: results of an economic evaluationJaime L Peters, Rob Anderson, Beverley Shields, et al.
BMJ Open|September 28, 2019
Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 yearsAnita Lynam, Timothy McDonald, Anita Hill, et al.
BMJ Open|December 29, 2020
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea-a MASTERMIND study protocolCatherine Angwin, Caroline Jenkinson, Angus Jones, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The Medical Journal of Australia|October 13, 2017
The prevalence of monogenic diabetes in Australia: the Fremantle Diabetes Study Phase IITimothy Me Davis, Ashley E Makepeace, Sian Ellard, et al.
Drug Discovery Today|November 8, 2016
Defining drug response for stratified medicineMike Lonergan, Stephen J Senn, Christine McNamee, et al.
Clinical Epigenetics|July 20, 2018
Genome-wide methylomic analysis in individuals with HNF1B intragenic mutation and 17q12 microdeletionRhian L Clissold, Beth Ashfield, Joe Burrage, et al.
Diabetes Care|September 19, 2014
Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetesNele Myngheer, Karel Allegaert, Andrew Hattersley, et al.
BMJ Global Health|May 21, 2021
Associations between low HDL, sex and cardiovascular risk markers are substantially different in sub-Saharan Africa and the UK: analysis of four population studiesRosamund Greiner, Moffat Nyrienda, Lauren Rodgers, et al.
Diabetes Research and Clinical Practice|May 17, 2017
A successful transition to sulfonylurea treatment in male infant with neonatal diabetes caused by the novel abcc8 gene mutation and three years follow-upDragan Katanic, Ivana Vorgučin, Andrew Hattersley, et al.
BMC Medical Genetics|May 21, 2017
Pancreas and gallbladder agenesis in a newborn with semilobar holoprosencephaly, a case reportRobert Hilbrands, Kathelijn Keymolen, Alex Michotte, et al.
BMJ Open|March 21, 2020
Strategies to identify individuals with monogenic diabetes: results of an economic evaluationJaime L Peters, Rob Anderson, Beverley Shields, et al.
BMJ Open|September 28, 2019
Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 yearsAnita Lynam, Timothy McDonald, Anita Hill, et al.
BMJ Open|December 29, 2020
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea-a MASTERMIND study protocolCatherine Angwin, Caroline Jenkinson, Angus Jones, et al.
Pageof 6